The Daily Med

THE DAILY EDITIONTHURSDAY, 5 NOVEMBER 2026

Case of the Day · Clinical Reasoning

Seizure with severe hyponatremia.

A 72-year-old taking a thiazide presents with confusion and a generalized seizure. Serum sodium is 112 mmol/L and glucose is normal.

What is the immediate treatment?

Drug Corner

Pharmacology in practice

PENICILLIN ANTIBIOTIC

Amoxicillin (oral)

Indication: Susceptible bacterial infections where antibiotic treatment is indicated.
Mechanism: Beta-lactam antibiotic that inhibits bacterial cell-wall synthesis.
Interactions: Probenecid may reduce renal excretion; monitor anticoagulation where clinically indicated.
Important adverse effect: Allergy including rare anaphylaxis; diarrhoea is common.
Dosing: Dose depends on infection, severity, susceptibility and renal function; use local indication-specific guidance.
Sources: FDA/DailyMed prescribing information: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82c0c5d1-df2d-4352-bd12-99f955af569e

Paper of the Day

Research, without the noise

Neurology · Acute ischemic stroke

Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion

MILD-MT randomized 300 analyzed patients in China with mild anterior-circulation large-vessel stroke and perfusion mismatch within 24 hours. At 90 days, mRS 0–1 occurred in 69.4% with endovascular therapy plus medical care versus 50.0% with medical care (OR 2.32, 95% CI 1.41–3.81); serious procedure-related complications occurred in 13.2%. Results apply to the selected imaging-defined population.

Authors: J. Liu and Others

Published: 23 October 2026 · New England Journal of Medicine

DOI: 10.1056/NEJMoa2609149

Read the original paper →

Journal Watch

What's new in medicine?

Infectious diseases · Diabetes and CKD

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP-4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

A nationwide target-trial emulation compared infection outcomes after treatment initiation; interpret its comparative estimates as observational, with possible residual confounding.

Endocrinology · Type 2 diabetes

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial

This event-driven active-comparator phase 3 trial assessed cardiovascular safety; interpret the non-inferiority finding with its prespecified margin and enrolled population in view.

Pulmonology · Airway clearance

High-Frequency Chest Wall Oscillation in Acute Respiratory Failure With Bronchial Hypersecretion: A Randomized Controlled Trial

In a single-centre RCT of 88 patients, therapeutic bronchoscopy was needed in 13.6% with oscillation versus 31.8% of controls, but the adjusted difference was not statistically significant (OR 0.336, 95% CI 0.111–1.021; P=0.055); secondary length-of-stay findings are exploratory.

Today's Topic

Build your clinical knowledge

Endocrinology · Thyroiditis

Thyroiditis: distinguish destructive hormone release from synthesis

Diagnosis / Testing

Classify by time course and symptoms (painful subacute, painless/postpartum, drug-induced or suppurative). Check TSH and free T4; uptake pattern and inflammatory markers can help distinguish destructive thyrotoxicosis from increased synthesis.

Treatment / Care Decisions

Destructive thyrotoxicosis is generally treated symptomatically; antithyroid drugs do not block release of stored hormone. Treat painful inflammation and replace thyroid hormone if a persistent hypothyroid phase develops.

Risk Assessment / Prognosis / Epidemiology

Follow thyroid function as phases change. Pregnancy/postpartum status, medication exposures, neck pain, fever and systemic toxicity change the differential and urgency.

Pathophysiology / Basic Science

Follicular inflammation releases stored hormone, often causing transient thyrotoxicosis followed by temporary hypothyroidism; recovery depends on cause.

Further reading: American Thyroid Association: Thyroiditis.